WithdrawnNot Applicable

Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery

Belgium0Started 2012-11

Plain-language summary

The incidence of complications after standard open pancreaticoduodenectomy for pancreatic or peri-ampullary tumours is around 50%. The amount of intra-operative blood loss is an important factor that determines the occurrence of postoperative complications. Therefore, any significant reduction of intra-operative blood loss will benefit the peri-operative course.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients, male or female, who undergo PD for a pancreatic or peri-ampullary tumor * Age between 18 to 80 years * Patients with and without pre-operative biliary drainage (for obstructive jaundice) * Pre-operative radiotherapy, chemotherapy, or biological is allowed * PD for IPMN is allowed Exclusion Criteria: * Planned concomitant surgical procedures such as simultaneous colonic resection etc. * Expected/planned reconstruction of the portal vein or superior mesenteric vein * Any arterial reconstruction at the time of surgery * Age \< 18years * Pregnancy * PD for chronic pancreatitis * PD for pancreatic trauma * PD for post-ERCP complications

What they're measuring

intra-operative blood loss

Timeframe: day 0 (at the end of surgery)

Trial details

NCT IDNCT01712971

SponsorBaki Topal

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Surgery trials